Winners of the 2025 ERA Awards and ERA Awards for Young Investigators were recognized at the 62nd ERA Congress. Pain coping skills training demonstrated benefits for patients on maintenance hemodialysis in a randomized clinical trial. Hemodialysis patients reporting shorter sleep or problems sleeping had a higher mortality risk in an observational study. Finerenone had kidney and cardiovascular benefits for patients with CKD even after an acute eGFR change occurred. Higher cardiovascular mortality risk was associated with higher CKM syndrome stage, research showed. The Annual Global Summit on Kidney Disease Innovations included sessions on rare diseases, human organ alternatives, and more A dual SGLT inhibitor may have ischemic benefits for patients with CKD, T2D, and cardiovascular risks, a study found. An analysis of CKD trials supported 3-year total slope as the primary slope-based outcome in randomized trials. Cyclophosphamide-rituximab therapy and minimal use of glucocorticoids in ANCA-associated vasculitis may reduce morbidity. The race of patients with ADPKD affects waitlist experience, allograft quality, and post-transplant outcomes, a study found. A study of real-world data found that tolvaptan reduced long-term kidney function decline in ADPKD. Using serum cystatin C as a biomarker for AKI could prove to be a valuable addition to diagnostic protocols, a study reports. In the phase 3 REGENCY trial, adding obinutuzumab to standard therapy for lupus nephritis led to better renal outcomes. A study found low rates of IgAN in the EU, but lower biopsy rates during the COVID-19 pandemic may have delayed diagnoses. Drs. Peter Richardson and George Wan of Mallinckrodt Pharmaceuticals discussed new data on terlipressin for HRS-AKI. Three kidney organizations will develop a consensus framework for Centers of Excellence in Glomerular Disease Care. Nefecon can safely be used to treat severe renal impairment and lowers proteinuria in patients with IgAN. Proteinuria trajectory is a major predictor of disease progression in children and adults with IgAN, a study found. Researchers fitted a face mask with a breath sensor that may be able to detect the presence of chronic kidney disease. This Freely Filtered episode discusses the KDIGO guideline draft for autosomal dominant polycystic kidney disease (ADPKD).